S&P 500   4,236.19 (-1.22%)
DOW   33,076.87 (-1.07%)
QQQ   356.11 (-1.43%)
AAPL   172.56 (-0.68%)
MSFT   313.82 (-2.48%)
META   301.38 (-1.77%)
GOOGL   133.25 (-0.69%)
AMZN   125.49 (-3.07%)
TSLA   248.35 (-1.29%)
NVDA   439.12 (-1.94%)
NIO   8.72 (-0.80%)
BABA   84.82 (-1.98%)
AMD   101.04 (-2.16%)
T   14.64 (-0.20%)
F   12.11 (-1.62%)
MU   68.59 (+0.93%)
CGC   0.70 (-5.36%)
GE   107.79 (-0.92%)
DIS   80.11 (-1.91%)
AMC   8.12 (-0.37%)
PFE   33.95 (+0.03%)
PYPL   57.81 (-1.28%)
NFLX   379.03 (-0.34%)
S&P 500   4,236.19 (-1.22%)
DOW   33,076.87 (-1.07%)
QQQ   356.11 (-1.43%)
AAPL   172.56 (-0.68%)
MSFT   313.82 (-2.48%)
META   301.38 (-1.77%)
GOOGL   133.25 (-0.69%)
AMZN   125.49 (-3.07%)
TSLA   248.35 (-1.29%)
NVDA   439.12 (-1.94%)
NIO   8.72 (-0.80%)
BABA   84.82 (-1.98%)
AMD   101.04 (-2.16%)
T   14.64 (-0.20%)
F   12.11 (-1.62%)
MU   68.59 (+0.93%)
CGC   0.70 (-5.36%)
GE   107.79 (-0.92%)
DIS   80.11 (-1.91%)
AMC   8.12 (-0.37%)
PFE   33.95 (+0.03%)
PYPL   57.81 (-1.28%)
NFLX   379.03 (-0.34%)
S&P 500   4,236.19 (-1.22%)
DOW   33,076.87 (-1.07%)
QQQ   356.11 (-1.43%)
AAPL   172.56 (-0.68%)
MSFT   313.82 (-2.48%)
META   301.38 (-1.77%)
GOOGL   133.25 (-0.69%)
AMZN   125.49 (-3.07%)
TSLA   248.35 (-1.29%)
NVDA   439.12 (-1.94%)
NIO   8.72 (-0.80%)
BABA   84.82 (-1.98%)
AMD   101.04 (-2.16%)
T   14.64 (-0.20%)
F   12.11 (-1.62%)
MU   68.59 (+0.93%)
CGC   0.70 (-5.36%)
GE   107.79 (-0.92%)
DIS   80.11 (-1.91%)
AMC   8.12 (-0.37%)
PFE   33.95 (+0.03%)
PYPL   57.81 (-1.28%)
NFLX   379.03 (-0.34%)
S&P 500   4,236.19 (-1.22%)
DOW   33,076.87 (-1.07%)
QQQ   356.11 (-1.43%)
AAPL   172.56 (-0.68%)
MSFT   313.82 (-2.48%)
META   301.38 (-1.77%)
GOOGL   133.25 (-0.69%)
AMZN   125.49 (-3.07%)
TSLA   248.35 (-1.29%)
NVDA   439.12 (-1.94%)
NIO   8.72 (-0.80%)
BABA   84.82 (-1.98%)
AMD   101.04 (-2.16%)
T   14.64 (-0.20%)
F   12.11 (-1.62%)
MU   68.59 (+0.93%)
CGC   0.70 (-5.36%)
GE   107.79 (-0.92%)
DIS   80.11 (-1.91%)
AMC   8.12 (-0.37%)
PFE   33.95 (+0.03%)
PYPL   57.81 (-1.28%)
NFLX   379.03 (-0.34%)
NASDAQ:INBS

Intelligent Bio Solutions (INBS) Stock Forecast, Price & News

$0.47
-0.01 (-1.88%)
(As of 01:03 PM ET)
Compare
Today's Range
$0.43
▼
$0.51
50-Day Range
$0.48
▼
$2.37
52-Week Range
$0.42
▼
$32.00
Volume
180,288 shs
Average Volume
125,124 shs
Market Capitalization
$1.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Intelligent Bio Solutions MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
8.68% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.10mentions of Intelligent Bio Solutions in the last 14 days
Based on 7 Articles This Week
Insider Trading
Acquiring Shares
$192 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($3.44) to ($2.83) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.68 out of 5 stars

See Top Rated MarketRank™ Stocks Here

INBS stock logo

About Intelligent Bio Solutions (NASDAQ:INBS) Stock

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

INBS Price History

INBS Stock News Headlines

October 2, 2023 | marketwatch.com
Intelligent Bio Solutions Shares Slide Premarket on Equity Offering
October 2, 2023 | msn.com
Why Is Intelligent Bio Solutions (INBS) Stock Down 52% Today?
October 3, 2023 | Behind the Markets (Ad)
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
October 2, 2023 | finance.yahoo.com
Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering
September 27, 2023 | finance.yahoo.com
Intelligent Bio Solutions Obtains ISO Recertification for its Intelligent Fingerprinting Drug Screening Business
September 27, 2023 | finance.yahoo.com
Intelligent Bio Solutions Obtains ISO Recertification for its Intelligent Fingerprinting Drug Screening Business
September 21, 2023 | finance.yahoo.com
Intelligent Bio Solutions Successfully Debuts Intelligent Fingerprinting Drug Screening Solution at the 2023 Workplace Health & Safety Show in Sydney, Australia
September 8, 2023 | finance.yahoo.com
Intelligent Bio Solutions Completes Critical Development Milestone in Plans to Add Ketamine and Tramadol to Fingerprint Drug Test
October 3, 2023 | Behind the Markets (Ad)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
September 5, 2023 | finance.yahoo.com
INBS: Australia Off to a Strong Start
August 25, 2023 | benzinga.com
Intelligent Bio Solutions (NASDAQ: INBS) Launches Global Expansion of Its Cutting-Edge Intelligent Drug Screening System
August 1, 2023 | finance.yahoo.com
Intelligent Bio Solutions Secures 8 New Customers with a Combined Workforce of Over 10,000 Employees Two Months into Product Launch in Australia
August 1, 2023 | finance.yahoo.com
Intelligent Bio Solutions Secures 8 New Customers with a Combined Workforce of Over 10,000 Employees Two Months into Product Launch in Australia
July 25, 2023 | finance.yahoo.com
Intelligent Bio Solutions Inc.'s (NASDAQ:INBS) Profit Outlook
July 11, 2023 | ecampusnews.com
Leveraging AI to Power Today’s Intelligent Campus
July 6, 2023 | finance.yahoo.com
Intelligent Bio Solutions Signs South American Distribution Agreement with TSCOM for Fingerprint Drug Screening System and Secures First Order
June 28, 2023 | finance.yahoo.com
Intelligent Bio Solutions Receives Guidance from U.S. FDA on a Regulatory Pathway for Expansion into the United States for its Intelligent Fingerprinting Drug Screening Cartridge
June 22, 2023 | au.finance.yahoo.com
INBS - Intelligent Bio Solutions Inc.
June 20, 2023 | finance.yahoo.com
Intelligent Bio Solutions Receives Non-Dilutive Grant Funding of USD $1.43 Million
June 5, 2023 | finance.yahoo.com
INBS: Fentanyl is the Latest Innovation
May 24, 2023 | finance.yahoo.com
Intelligent Bio Solutions to Participate in the LD Micro Invitational XIII on June 6th
May 16, 2023 | finance.yahoo.com
Intelligent Bio Solutions Plans to Add Fentanyl Testing as it Further Enhances its Fingerprint-Based Drug Screening Solution
May 12, 2023 | finanznachrichten.de
Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. Reports Fiscal 2023 Third Quarter Financial Results and Operational Highlights
May 11, 2023 | finance.yahoo.com
Intelligent Bio Solutions Inc. Reports Fiscal 2023 Third Quarter Financial Results and Operational Highlights
May 2, 2023 | finance.yahoo.com
Intelligent Bio Solutions Scales Reach Throughout Asia-Pacific Region with Addition of Sales Team in Australia, New Distribution Hub and Office Facility
April 28, 2023 | marketwatch.com
UK Food Processing Equipment Manufacturer Latest to Adopt Intelligent Bio Solutions' Portable Fingerprint Drug Testing Solution
April 26, 2023 | finance.yahoo.com
UK Food Processing Equipment Manufacturer Latest to Adopt Intelligent Bio Solutions’ Portable Fingerprint Drug Testing Solution
See More Headlines
Receive INBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter.

INBS Company Calendar

Last Earnings
8/24/2023
Today
10/03/2023
Next Earnings (Estimated)
11/23/2023
Fiscal Year End
6/30/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:INBS
CUSIP
N/A
CIK
1725430
Web
gbs.inc
Phone
646-828-8258
Fax
N/A
Employees
51
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-10,630,000.00
Net Margins
N/A
Pretax Margin
-848.45%
Return on Equity
-104.58%
Return on Assets
-53.15%

Debt

Debt-to-Equity Ratio
0.11
Current Ratio
0.66
Quick Ratio
0.49

Sales & Book Value

Annual Sales
$1.26 million
Price / Sales
0.87
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.58 per share
Price / Book
0.30

Miscellaneous

Outstanding Shares
2,330,000
Free Float
2,305,000
Market Cap
$1.10 million
Optionable
Not Optionable
Beta
3.81
A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Harry Simeonidis (Age 56)
    Pres & CEO
    Comp: $310.79k
  • Mr. Spiro Kevin Sakiris B.Bus (Age 61)
    C.A., CA, Dip Law, Chief Financial Officer
    Comp: $274.43k
  • Ms. Victoria Gavrilenko (Age 40)
    Operations Mang.
  • Mr. Alex Arzeno
    VP of Investor Relations

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













INBS Stock - Frequently Asked Questions

How have INBS shares performed in 2023?

Intelligent Bio Solutions' stock was trading at $3.9980 on January 1st, 2023. Since then, INBS stock has decreased by 88.2% and is now trading at $0.47.
View the best growth stocks for 2023 here.

Are investors shorting Intelligent Bio Solutions?

Intelligent Bio Solutions saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 132,000 shares, an increase of 33.5% from the August 31st total of 98,900 shares. Based on an average daily volume of 45,600 shares, the days-to-cover ratio is currently 2.9 days. Approximately 8.7% of the shares of the company are short sold.
View Intelligent Bio Solutions' Short Interest.

When is Intelligent Bio Solutions' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 23rd 2023.
View our INBS earnings forecast.

How were Intelligent Bio Solutions' earnings last quarter?

Intelligent Bio Solutions Inc. (NASDAQ:INBS) released its quarterly earnings results on Thursday, August, 24th. The company reported ($1.91) EPS for the quarter, missing the consensus estimate of ($1.66) by $0.25. The firm earned $0.44 million during the quarter, compared to analysts' expectations of $0.49 million.

When did Intelligent Bio Solutions' stock split?

Intelligent Bio Solutions shares reverse split on Friday, February 10th 2023. The 1-20 reverse split was announced on Friday, February 10th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 10th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What is Intelligent Bio Solutions' stock symbol?

Intelligent Bio Solutions trades on the NASDAQ under the ticker symbol "INBS."

How do I buy shares of Intelligent Bio Solutions?

Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Intelligent Bio Solutions' stock price today?

One share of INBS stock can currently be purchased for approximately $0.47.

How much money does Intelligent Bio Solutions make?

Intelligent Bio Solutions (NASDAQ:INBS) has a market capitalization of $1.10 million and generates $1.26 million in revenue each year.

How can I contact Intelligent Bio Solutions?

Intelligent Bio Solutions' mailing address is 142 WEST 57TH ST FL11, NEW YORK NY, 10019. The official website for the company is gbs.inc. The company can be reached via phone at 646-828-8258 or via email at investor.relations@gbs.inc.

This page (NASDAQ:INBS) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -